Skip to main content
    P

    Precigen Inc (PGEN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $4.29
    -0.01 (-0.23%)

    Market Cap: $1.54B

    Last updated: Nov 17, 2026 at 4:33 PM ET

    Precigen Inc (PGEN) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Precigen (PGEN) has a market cap of $1.54B and an enterprise value of $1.62B. Revenue grew 2691.26% over the last 12 months from the 12 months before. Its share count is up 16.63% from a year earlier.

    Total Valuation

    Enterprise value is 5.14% above the market cap, as debt exceeds cash.

    Market Cap$1.54B
    Enterprise Value$1.62B
    Latest price (Nov 17, 2026)$4.29

    Key Dates

    The next earnings report is expected on Mar 23, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 23, 2027 (expected)
    Last Earnings DateNov 4, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.38% in the quarter ended Sep 30, 2026 and grew 13.95% a year over 2 years.

    Shares Outstanding358.25M
    Shares Change (YoY)+16.63%
    Shares Change (QoQ)+0.38%
    Share Count Growth (2Y CAGR)+13.95%

    Valuation Ratios

    Sales and book value multiples are 9.8x and 18.3x.

    P/E Ratio98.4x
    Forward P/E17.9x
    P/S Ratio9.8x
    Forward P/S6.4x
    P/B Ratio18.3x
    P/TBV Ratio23.2x

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 42.2x EBITDA.

    EV / Earnings66.4x
    EV / Sales10.4x
    EV / EBITDA42.2x
    EV / EBIT47.7x

    Price Statistics

    The stock is down 11.55% over 52 weeks and trades 35.29% below its 50-day average.

    Beta (1Y)1.71
    52-Week Change-11.55%
    1-Month Change-35.59%
    3-Month Change-40.08%
    6-Month Change+3.13%
    5-Year Change+43.69%
    10-Year Change-73.41%
    Total Return (1Y)-11.55%
    Total Return (3Y CAGR)+53.75%
    Total Return (5Y CAGR)+2.78%
    Return vs SPY (1Y)-23.11%
    Max Drawdown (1Y)-50.70%
    Max Drawdown (3Y)-64.17%
    Sharpe Ratio (1Y)-0.15
    Correlation with SPY (1Y)0.29
    50-Day Average$6.63
    200-Day Average$5.28
    52-Week Range$3.04 to $8.98
    RSI (14 Days)32.1
    Average Volume (20 Days)7.79M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 5.58x current liabilities, and total debt is 1.12x shareholder equity.

    Current Ratio5.58x
    Quick Ratio4.83x
    Debt / Equity1.12x
    Debt / EBITDA2.46x
    Interest Coverage2.88x

    Returns and Efficiency

    Return on invested capital is 18.93% and return on equity is 29.13% over the last 12 months.

    Return on Equity (ROE)29.13%
    Return on Assets (ROA)11.51%
    Return on Invested Capital (ROIC)18.93%
    Return on Capital Employed (ROCE)18.74%
    ROA (5Y Average)-64.19%
    Asset Turnover0.81x
    Inventory Turnover0.62x
    Receivables Turnover1.85x
    Cash Conversion Cycle615 days

    Taxes

    Income tax took 0.81% of pretax income over the last 12 months.

    Income Tax (TTM)$200.00K
    Effective Tax Rate0.81%

    Scores

    PGEN has an Altman Z-Score of -5.89, in the distress zone below 1.81, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Altman Z-Score-5.89
    Altman Z ZoneDistress
    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was $156.09M over the last 12 months.

    Revenue$156.09M
    Revenue Growth (YoY)+2691.26%
    Gross Profit$142.62M
    Operating Income$33.63M
    Pretax Income$24.61M
    Net Income$24.41M
    EBITDA$38.34M
    EBIT$33.99M
    Reported EPS (TTM)$0.04

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 39.50% of the $212.10M in total assets.

    Cash and Equivalents$14.96M
    Total Debt$94.26M
    Net Debt$79.30M
    Net Debt Per Share$0.22
    Working Capital$140.97M
    Shareholder Equity$83.79M
    Book Value Per Share$0.23
    Tangible Book Value$66.33M
    Tangible Book Per Share$0.19
    Total Assets$212.10M
    Total Liabilities$128.31M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $1.10M of capital spending, operating cash flow left -$74.32M of free cash flow.

    Operating Cash Flow-$73.21M
    Capital Expenditures$1.10M
    Free Cash Flow-$74.32M
    FCF Per Share-$0.21
    Depreciation and Amortization$5.26M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 21.55%.

    Gross Margin91.37%
    Operating Margin21.55%
    Pretax Margin15.76%
    Net Margin15.64%
    EBITDA Margin24.56%
    EBIT Margin21.77%
    FCF Margin-47.61%
    Gross Margin (5Y Average)35.87%

    Growth

    Revenue fell 28.87% a year over 3 years.

    Revenue Growth (3Y CAGR)-28.87%
    Revenue Growth (5Y CAGR)-21.26%
    Book Value Per Share Growth (2Y CAGR)-62.54%
    Tangible Book Per Share Growth (2Y CAGR)-80.30%

    Revenue and profit by year

    Dividends and Yields

    PGEN does not pay a dividend. Its free cash flow yield is -4.84%.

    Earnings Yield1.02%
    FCF Yield-4.84%
    Buyback Yield0.00%
    Shareholder Yield0.00%

    Peer Position

    Against 10 similar companies, PGEN has the 7th highest P/S.

    P/S Ratio9.8x vs 19.5x median
    ROIC18.93% vs -57.88% median
    Revenue Growth (Trailing 4 Quarters, YoY)+2691.26% vs +23.09% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 575.57% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+575.57%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewOvervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About PGEN

    What is PGEN's market cap?

    Precigen has a market cap of $1.54B. Its enterprise value, which adds debt and subtracts cash, is $1.62B.

    What is PGEN's P/E ratio?

    Precigen has a trailing P/E ratio of 98.4x and a forward P/E of 17.9x.

    How many shares of PGEN are outstanding?

    Precigen has 358.25M shares outstanding. The count is up 16.63% from a year earlier.

    Does PGEN pay a dividend?

    No. Precigen does not pay a dividend.

    How much debt does PGEN have?

    Precigen has $94.26M of total debt and $14.96M of cash and equivalents, a net debt position of $79.30M.